Research Library Coenzyme
Coenzyme

NAD+

A coenzyme found in every living cell, essential for energy metabolism and DNA repair — and one of the most-studied molecules in the rapidly growing field of aging biology.

Also Known As Nicotinamide Adenine Dinucleotide, NAD, Coenzyme I
Type Coenzyme / Dinucleotide
Research Area Cellular Energy Production, DNA Repair, Sirtuin Activation, Aging Research
Status Research Use Only
Molecular structure of NAD+ — animated Molecular structure of NAD+
Hover to pause rotation
3D Animated Structure
🔬

What is it?

NAD+ (nicotinamide adenine dinucleotide) is not technically a peptide — it's a coenzyme, a small molecule that helps enzymes do their job. But it's included in the research library because it's one of the most important molecules in cell biology and because it functions in closely related research contexts to many of the peptides studied here.

Every cell in your body uses NAD+ as an essential helper molecule. It's the central currency of cellular energy metabolism — shuttling electrons through the reactions that generate ATP (your cells' energy currency). It's also required by sirtuins (proteins linked to longevity research), PARPs (DNA repair enzymes), and CD38 (an enzyme involved in immune signaling). No NAD+, no life — it's that fundamental.

What's changed recently in the research community is a focus on NAD+ levels declining with age. Multiple published studies have documented that NAD+ concentrations fall by 50% or more between youth and old age in multiple tissue types. This decline has been linked in laboratory models to reduced mitochondrial function, impaired DNA repair, and disrupted circadian rhythms. The resulting interest in NAD+ restoration strategies has produced one of the most active research areas in contemporary biology.

📡 Weekly peptide research updates — regulatory updates, new compound profiles, COA alerts.

⚠️ FDA PCAC: -- days left

No spam. Unsubscribe anytime. 7 peptides under review — see what's at stake →

Why Researchers Care

NAD+ sits at the intersection of energy metabolism, epigenetics, DNA repair, and aging — making it a uniquely cross-disciplinary research target.

  • NAD+ is required by sirtuins (SIRT1-SIRT7) — a protein family central to epigenetic regulation, mitochondrial biogenesis, and stress response. Sirtuin activation requires NAD+, making NAD+ levels a rate-limiting factor in sirtuin function and connecting it directly to longevity research.
  • Published research has documented age-related NAD+ decline across multiple tissues and species, connecting NAD+ biology to some of the most-studied mechanisms of biological aging and spurring clinical trials examining whether restoring levels produces measurable effects.
  • NAD+ precursors (NMN, NR) and direct NAD+ supplementation strategies have become major research areas, with human clinical trials examining pharmacokinetics, tissue distribution, and downstream biomarker changes.
🔬 Free Tools

Put this research to work

7 free research tools built around exactly this kind of compound data. No paywall, no credit card.

Explore All Free Tools →
⚙️

How It Works

NAD+ accepts electrons from metabolic reactions (becoming NADH), then delivers those electrons to the mitochondrial electron transport chain to generate ATP. As an oxidized coenzyme (NAD+), it also activates sirtuins, which deacetylate histones and other proteins to regulate gene expression, DNA repair, and mitochondrial health. The cycle of NAD+ being reduced (gaining electrons, becoming NADH) and re-oxidized (losing electrons, returning to NAD+) is repeated thousands of times per cell per day — making it one of the most heavily cycled molecules in living systems.

Think of it like this 🧠

If your cell is a factory, NAD+ is like the forklifts that move materials between departments. Without enough forklifts, the energy production line slows down, the DNA repair team can't get supplies, and the management (sirtuins) can't get to work. When NAD+ levels drop with age, it's like the factory is operating with fewer and fewer forklifts — everything gets slower and less efficient.

📐

Clinical Protocol Context

Research Disclaimer: The following reflects published clinical and preclinical research and is not medical advice. Consult a licensed healthcare provider before making any health decisions.

NAD+ has been studied in IV and oral forms across multiple published human trials, most frequently via precursor supplementation (NMN, NR) since direct NAD+ oral bioavailability is limited. IV NAD+ infusion is also used in clinical settings with published protocols.

Dosing Ranges from Published Research
NMN Oral (Human RCT) Yoshino M et al. (2021, Science) conducted the first human RCT with NMN (250 mg/day oral) for 10 weeks in women, showing increased NAD+ levels in blood and improvements in muscle insulin signaling. Wan et al. (2022, Nat Aging) used 600–1200 mg/day NMN orally.
IV NAD+ Infusion Published protocols and clinical research have used IV NAD+ at 500–1000 mg over 2–4 hours. Infusion protocols described by Braidy et al. and clinical infusion centers document tolerability at this dose range. The slow infusion rate is required due to flushing/histamine effects at faster rates.
NR Oral (Human) Trammell SAJ et al. (2016, Nat Commun) administered NR (nicotinamide riboside) 250 mg/day and 500 mg/day oral for 8 weeks. Blood NAD+ rose dose-dependently. Dellinger RW et al. (2017) used 1000 mg NR/day.
Routes, Duration & Timing
IV InfusionSlow infusion (2–4 hours) required to avoid histamine-mediated side effects (flushing, chest tightness). Direct NAD+ reaches peak blood levels immediately after infusion.
Oral (Precursors)NMN and NR administered once daily in clinical trials. Blood NAD+ elevation measurable at 4 hours post-dose; sustained elevation documented at 8 weeks with once-daily administration.
StorageNAD+ powder stable at −20°C. IV formulations in sterile saline require refrigeration. Oral NMN/NR supplements stored at room temperature (stable for 24 months if kept dry).

Key References: Yoshino M et al. (2021). NMN RCT in overweight women. Science. · Trammell SA et al. (2016). NR dose-response in humans. Nat Commun. · Wan Z et al. (2022). NMN in older adults. Nat Aging.

Fun Facts

🏆

NAD+ was first discovered in 1906 by Arthur Harden, who won a Nobel Prize for it in 1929 — making it one of the oldest-known coenzymes still actively generating new research findings and clinical trials nearly 120 years later.

📉

NAD+ levels in skeletal muscle drop by approximately 50% between ages 30 and 70 in human studies — a decline rate that has driven enormous investment in NAD+ restoration research and the development of precursor compounds like NMN and NR.

🧬

NAD+ is consumed (not just used) by PARP enzymes during DNA repair — a single strand break can consume hundreds of NAD+ molecules. This means significant DNA damage events can temporarily crash a cell's entire NAD+ pool.

📋

COA & Batch Documentation

Every batch of NAD+ with full Certificate of Analysis documentation.

📄
HPLC Certificate
Documentation pending batch assignment
🔬
Mass Spec Analysis
Documentation pending batch assignment
Purity Report
Documentation pending batch assignment
🧪
Sterility Test
Documentation pending batch assignment
Learn about our COA verification process →